Company: ACBM
Filing Date: 2025-07-11
Form Type: 10-Q
Source: 0001640334-25-001169
Chunk: 35

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-11
Form: 10-Q
Item: Item 1
Chunk 35
---
 affect, our internal control over financial reporting.

 15Table of Contents

PART II – OTHER INFORMATION

Item 6: Exhibits

Exhibits

Exhibit Number Description of Exhibits31.1* Section 302 Certificate of Chief Executive Officer and Principal Financial Officer.32.1** Section 906 Certificate of Chief Executive Officer and Principal Financial Officer.101.INS* Inline XBRL Instance Document*101.SCH* Inline XBRL Taxonomy Extension Schema Document*101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document*101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document*101.LAB* Inline XBRL Taxonomy Extension Label Linkbase Document*101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document*104* Document Set

*Filed herewith**Furnished herewith

 16Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 ACRO BIOMEDICAL CO., LTD.     Dated: July 11, 2025By:/s/ Pao-Chi Chu   Pao-Chi Chu   Chief Executive Officer and Chief    Financial Officer 

 17